Navigation Links
FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
Date:2/14/2013

EVERETT, Wash., Feb. 14, 2013 /PRNewswire/ -- The United States Food and Drug Administration (FDA) announced today it has granted the new automated, multifunctional ESA615 Electrical Safety Analyzer 510(k) clearance. Now medical device quality and safety professionals can test to the newest safety standards in just minutes using this all-in-one automated test tool.

(Photo: http://photos.prnewswire.com/prnh/20130214/SF60261)

(Logo: http://photos.prnewswire.com/prnh/20120130/SF43337LOGO-b)

The ESA615 offers built-in standardized test sequences so every test is executed quickly and accurately with clear pass/fail indication of test results. It tests to the new IEC62353 (VDE751), IEC60601-1 (2nd and 3rd editions), ANSI/AAMI ES-1, NFPA-99, and AS/NZS 3551 standards. Not only does it test to the newest global standards, customers can interface in English, French, German, Spanish, Italian or Portuguese.

With built-in automation, there is no need to carry a laptop for complete automated testing and documentation of electrical safety tests. Quick data entry and error-free reporting reduce test time and improve quality of test results making data management easy.

"The ESA615 brings built-in automated testing to the palm of your hand," explains Shirin Khanna , Product Marketing Manager for Fluke Biomedical. "ESA615 provides exceptional value by getting the job done accurately, faster, easier, and with better technology than ever before."

For more information on the new ESA615 Electrical Safety Analyzer, global electrical safety standards, product demonstration/training materials, and the entire line of Fluke Biomedical electrical safety testers, visit www.flukebiomedical.com/ESA.

About Fluke Biomedical
Fluke Biomedical is the premiere, global provider of test and measurement equipment and services to the healthcare industry. We strive to be the best at delivering innovative solutions to improve quality of global health. We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals. For more information on Fluke Biomedical, visit www.flukebiomedical.com.

For More Information
Shannon Deveny
Marketing Communications Manager
(425) 446-6064
Shannon.deveny@fluke.com


'/>"/>
SOURCE Fluke Biomedical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
(Date:2/10/2016)... 10, 2016 --> ... & Gas), and Spectroscopy Market by Industry (Oil & Gas, ... & Paper, Metal & Mining, and Others), And Geography ... global market is expected to grow to USD 3.9 ... between 2015 and 2020. Browse 82 market ...
(Date:2/10/2016)... CSI Specialty Group (CSI) expanded its specialty ... Specialty Pharmacy Podcast. A free, weekly show, the Specialty ... education, discussion and context amongst specialty pharmacy peers and ... --> The Specialty Pharmacy Podcast, hosted by industry ... Suzette DiMascio, CHE, CMCE, CPC, is available for streaming ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... change in their patients. Research shows that the Goal Attainment Scale (GAS) captures ... overcome this challenge and learn more about the Goal Attainment Scale, Education Resources ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Club at Ibis ... prestigious Distinguished Emerald Club of the World award, as determined by the annual ... the most respected trade publications serving private clubs. , “We’d like to congratulate ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | Ticket ... Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation , ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of ... in the state still face a lot of restrictions as to where they can ... for private, personal use” and that cannabis “may not be consumed openly or publicly.” ...
Breaking Medicine News(10 mins):